British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: An update on recommendations for practice 2023
- PMID: 38043220
- DOI: 10.1016/j.ejogrb.2023.11.013
British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: An update on recommendations for practice 2023
Keywords: High grade intraepithelial lesion; Human papiloma virus; Lichen sclerosus; National guideline; Vulval cancer; Vulval/vulvar intraepithelial neoplasia; Vulvar cancer.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JM - None to declare. PB - None to declare. LH - None to declare. AA- None to declare. LB- Works for Perci Health Ltd, 1 Vincent Square, London, SW1P 2PN and director of Buckley Consultants Ltd. KE- Royal College of Obstetricians and Gynaecologists Workforce Fellow Jan 2022-Dec 2022. Paid for 8 h/week via her organisation. CF – Has received payments for participation on a Data Safety Monitoring Board or Advisory Board for Glaxo Smith Klein, Roche, Ethicon, Astra Zeneca MSD (Merck & Co., Inc). RG – Has received payments for lectures from Astra Zeneca, Oncoinvent and MSD. AT - Has received financial support to attend meetings and for participation on a Data Safety Monitoring Board or Advisory Board from MSD.
Comment on
-
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD013479. doi: 10.1002/14651858.CD013479. Cochrane Database Syst Rev. 2019. PMID: 31755549 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
